Existing clinical trial supply models are faced with a number of challenges. Increased market competition, growing clinical trial complexity, a significant rise in clinical trial initiations globally, and pricing pressures are just some of the factors necessitating strategic shifts in how clinical trial supply models operate.
Reporting for Clinical Trials Arena, reporter Ross Law spoke with Arnaud Dourlens, head of clinical supply chain operations at Sanofi, to learn what advancements and technological innovations can serve to drive operational resilience and mitigate ongoing pressures in the modern clinical trial supply chain.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
This episode was recorded at Arena International Events Group’s 2026 Clinical Trial Supply (CTS) conference, which took place in Barcelona, Spain on 24-25 February.
You can listen to the podcast below:
